Search research articles
Contact Us
Filters
Showing results (41-50 of 189) with videos related to
Page
of 19
Sort By:
Metabolic Brain Disease
|
October 11, 2016
Decreased sensitivity of palmitoyl protein thioesterase 1-deficient neurons to chemical anoxia
Meredith Meyer, Attila D Kovács, David A Pearce
Environmental Microbiome
|
July 18, 2025
Daily turnover of airborne bacterial communities in the sub-Antarctic
Lucie A Malard, Peter Convey, David A Pearce
Experimental Cell Research
|
September 21, 2010
A novel interaction of CLN3 with nonmuscle myosin-IIB and defects in cell motility of Cln3(-/-) cells
Amanda L Getty, Jared W Benedict, David A Pearce
Neurobiology of Disease
|
February 18, 2006
Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease
Attila D Kovács, Jill M Weimer, David A Pearce
Expert Opinion on Medical Diagnostics
|
March 16, 2013
Diagnosis of neuronal ceroid lipofuscinosis: mutation detection strategies
Amanda L Getty, Paul G Rothberg, David A Pearce
Human Molecular Genetics
|
March 30, 2013
The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis
Jake N Miller, Chun-Hung Chan, David A Pearce
Human Molecular Genetics
|
March 8, 2007
Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells
Seasson Phillips Vitiello, Devin M Wolfe, David A Pearce
Human Molecular Genetics
|
August 6, 2008
Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models
Chun-Hung Chan, Hannah M Mitchison, David A Pearce
Brain : a Journal of Neurology
|
June 2, 2006
Another disorder finds its gene
Denia Ramirez-Montealegre, Paul G Rothberg, David A Pearce
Human Molecular Genetics
|
September 11, 2014
The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy
Jake N Miller, Attila D Kovács, David A Pearce
Page
of 19
Search research articles
Search
Showing results (41-50 of 189) with videos related to
Sort By:
Page
of 19
Metabolic Brain Disease
|
October 11, 2016
Decreased sensitivity of palmitoyl protein thioesterase 1-deficient neurons to chemical anoxia
Meredith Meyer, Attila D Kovács, David A Pearce
Environmental Microbiome
|
July 18, 2025
Daily turnover of airborne bacterial communities in the sub-Antarctic
Lucie A Malard, Peter Convey, David A Pearce
Experimental Cell Research
|
September 21, 2010
A novel interaction of CLN3 with nonmuscle myosin-IIB and defects in cell motility of Cln3(-/-) cells
Amanda L Getty, Jared W Benedict, David A Pearce
Neurobiology of Disease
|
February 18, 2006
Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease
Attila D Kovács, Jill M Weimer, David A Pearce
Expert Opinion on Medical Diagnostics
|
March 16, 2013
Diagnosis of neuronal ceroid lipofuscinosis: mutation detection strategies
Amanda L Getty, Paul G Rothberg, David A Pearce
Human Molecular Genetics
|
March 30, 2013
The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis
Jake N Miller, Chun-Hung Chan, David A Pearce
Human Molecular Genetics
|
March 8, 2007
Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells
Seasson Phillips Vitiello, Devin M Wolfe, David A Pearce
Human Molecular Genetics
|
August 6, 2008
Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models
Chun-Hung Chan, Hannah M Mitchison, David A Pearce
Brain : a Journal of Neurology
|
June 2, 2006
Another disorder finds its gene
Denia Ramirez-Montealegre, Paul G Rothberg, David A Pearce
Human Molecular Genetics
|
September 11, 2014
The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy
Jake N Miller, Attila D Kovács, David A Pearce
Page
of 19